Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Clinical trial NCT02749032 · COMPLETED

Trial details

NCT number: NCT02749032
Sponsor: Michael A. Nauck
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2011-11-01
Primary completion: 2014-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.